Integrating cheminformatic analysis in combinatorial chemistry

Current Opinion in Chemical Biology

Volumn 8, Issue 4, 2004, Pages 407-411

  Blake, James F ^a  

^a ARRAY BIOPHARMA INC   (United States)

Author keywords

AA; Alternating Algorithm; CDK2; cyclin dependent kinase 2

Indexed keywords

ABSORBENT; TOPICAL AGENT;

ANALYTIC METHOD; CHEMICAL ANALYSIS; DATA ANALYSIS; DATA BASE; PHYSICAL CHEMISTRY; REVIEW; SCREENING;

COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; INFORMATICS; PEPTIDE LIBRARY;

EID: 3342884458     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2004.04.017     Document Type: Review

References (30)

1. Blake J.F., Laird E.R. Recent advances in virtual ligand screening. Ann Rep Med Chem. 38:2003;305-314
2. Weaver DC: Applying data mining techniques to library design, lead generation, and lead optimization. Curr Opin Chem Biol 2004, 8:in press.
3. Spencer R.W. High-throughput screening of historic collections: Observations on file size, biological targets and file diversity. Biotechnol Bioeng. 61:1998;61-67
4. Dolle R.E. Comprehensive survey of combinatorial library synthesis: 2002. J Comb Chem. 5:2003;693-753 A detailed survey of combinatorial libraries published during 2002, with 388 distinct examples. For many entries, the biological target and activity of the compounds are presented.
5. Martin Y.C. Diverse viewpoints on computational aspects of molecular diversity. J Comb Chem. 3:2001;231-250
6. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 44:2000;235-249
7. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46:2001;3-26
8. Hann MH, Oprea TI: Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 2004, 8:in press.
9. Hopkins A.L., Groom C.R. The druggable genome. Nat Rev Drug Discov. 1:2002;727-730
10. Milne G.M. Jr. Pharmaceutical productivity - the imperative for new paradigms. Ann Rep Med Chem. 38:2003;383-396 This paper presents a compelling analysis of research and development productivity in the pharmaceutical industry. Milne argues that library design should be made a top priority within the research organization staffed by the most gifted researchers.
11. Proudfoot J.R. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. Bioorg Med Chem Lett. 12:2002;1647-1650
12. Oprea T.I., Davis A.M., Teague S.J., Leeson P.D. Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci. 41:2001;1308-1315
13. Veber D.F., Johnson S.R., Cheng H.-Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 45:2002;2615-2623
14. Blake J.F. Examination of the computed molecular properties of compounds selected for clinical development. BioTechniques. 34:2003;S16-S20
15. Wenlock M.C., Austin R.P., Barton P., Davis A.M., Leeson P.D. A comparison of physiochemical property profiles of development and marketed oral drugs. J Med Chem. 46:2003;1250-1256
16. Oprea T.I. Current trends in lead discovery: Are we looking for the appropriate properties? J Comput Aided Mol Des. 16:2002;325-334
17. Venkatesh S., Lipper R.A. Role of the development scientist in compound lead selection and optimization. J Pharm Sci. 89:2000;145-154
18. Vieth M., Siegel M.G., Higgs R.E., Watson I.A., Robertson D.H., Savin K.A., Durst G.L., Hipskind P.A. Characteristic physical properties and structural fragments of marketed oral drugs. J Med Chem. 47:2004;224-232
19. Sauer W.H.B., Schwarz M.K. Molecular shape diversity of combinatorial libraries: A prerequisite for broad bioactivity. J Chem Inf Comput Sci. 43:2003;987-1003
20. Martin Y.C., Kofron J.L., Traphagen L.M. Do structurally similar molecules have similar biological activity? J Med Chem. 45:2002;4350-4358 This paper challenges many long held beliefs relating to file diversity and the design of combinatorial libraries. The empirical observations provide guidance for the construction of combinatorial libraries designed for general hit identification.
21. Rose S., Stevens A. Computational design strategies for combinatorial libraries. Curr Opin Chem Biol. 7:2003;331-339
22. Jamois E.A. Reagent-based and product-based computational approaches in library design. Curr Opin Chem Biol. 7:2003;326-330
23. Laird ER, Blake JF: Structure-based generation of viable leads from small combinatorial libraries. Curr Opin Drug Discov Dev 2004, in press.
24. Miller J.L., Bradley E.K., Teig S.L. Luddite: An informative-theoretic library design tool. J Chem Inf Comput Sci. 43:2003;47-54
25. Bradley E.K., Miller J.L., Saiah E., Grootenhuis P.D. Informative library design as an efficient strategy to identify and optimize leads: Application to cyclin-dependent kinase 2 antagonists. J Med Chem. 46:2003;4360-4364
26. Evensen E., Eksterowicz J.E., Stanton R.V., Oshiro C., Grootenhuis P.D.J., Bradley E.K. Comparing performance of computational tools for combinatorial library design. J Med Chem. 46:2003;5125-5128
27. Ewing T.J., Makino S., Skillman A.G., Kuntz I.D. DOCK4.0: Search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des. 15:2001;411-428
28. Wright T., Gillet V.J., Green D.V.S., Pickett S.D. Optimizing the size and configuration of combinatorial libraries. J Chem Inf Comput Sci. 43:2003;381-390
29. Young S.S., Wang M., Gu F. Design of diverse and focused combinatorial libraries using an alternating algorithm. J Chem Inf Comput Sci. 43:2003;1916-1921
30. Clark R.D., Kar J., Lakshmi A., Soltanshahi F. OptDesign: Extending optimizable k-dissimilarity selection to combinatorial library design. J Chem Inf Comput Sci. 43:2003;829-836